Progressive brain function changes in patients with neuromyelitis optica: insights from resting-state fMRI

Jiyuan Wang1,2, Jing Huang1,2, Xiong Kang1,2

  • 1Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, No.45 Changchun Street, Beijing, 100053, Xicheng District, China.

PubMed
Summary

Neuromyelitis Optica (NMO) patients show progressive brain function decline, with reduced neural activity in key areas over time. These changes correlate with clinical disability and visual acuity, suggesting ALFF as a biomarker for disease progression.

Related Concept Videos